Загрузка...
Role of rituximab in first-line treatment of chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is a biologically heterogeneous illness that primarily afflicts the elderly. For many decades, the initial therapy for most patients requiring treatment was limited to single-agent alkylator therapy. Within the last two decades, we have seen remarkable progress in...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3039008/ https://ncbi.nlm.nih.gov/pubmed/21339937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S5855 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|